Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis

Neurobiology of Aging

Volumn 36, Issue 3, 2015, Pages 1600.e5-1600.e8

  Morgan, Sarah ^a,b   Shoai, Maryam ^a,b   Fratta, Pietro ^b   Sidle, Katie ^b   Orrell, Richard ^b   Sweeney, Mary G ^c   Shatunov, Aleksey ^d   Sproviero, William ^d   Jones, Ashley ^d   Al Chalabi, Ammar ^d   Malaspina, Andrea ^e   Houlden, Henry ^b   Hardy, John ^a,b   Pittman, Alan ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

ALS; Amyotrophic lateral sclerosis; Diagnosis; Genetic; MiSeq; Neurogenetics; Next generation sequencing; NGS; Sequencing

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST; DNA SEQUENCE; EXPLORATORY RESEARCH; FAMILIAL DISEASE; GENE SEQUENCE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL TECHNOLOGY; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; RELIABILITY; ECONOMICS; GENETICS; HIGH THROUGHPUT SEQUENCING; PROCEDURES; REPRODUCIBILITY; TRENDS;

AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; POLYMORPHISM, GENETIC; REPRODUCIBILITY OF RESULTS;

EID: 84923602414     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.12.017     Document Type: Article

References (23)

1. Al-Chalabi A., Lewis C.M. Modelling the effects of penetrance and family size on rates of sporadic and familial disease. Hum. Hered. 2011, 71:281-288.
2. Beck J., Pittman A., Adamson G., Campbell T., Kenny J., Houlden H., Rohrer J.D., de Silva R., Shoai M., Uphill J., Poulter M., Hardy J., Mummery C.J., Warren J.D., Schott J.M., Fox N.C., Rossor M.N., Collinge J., Mead S. Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiol. Aging. 2014, 35:261-265.
3. Cronin S., Greenway M.J., Prehn J.H., Hardiman O. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. J.Neurol. Neurosurg. Psychiatry 2007, 78:984-986.
4. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
5. Del Bo R., Tiloca C., Pensato V., Corrado L., Ratti A., Ticozzi N., Corti S., Castellotti B., Mazzini L., Sorarù G., Cereda C., D'Alfonso S., Gellera C., Comi G.P., Silani V. Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J.Neurol. Neurosurg. Psychiatry 2011, 82:1239-1243. SLAGEN Consortium.
6. Drepper C., Herrmann T., Wessig C., Beck M., Sendtner M. C-terminal FUS/TLS mutations in familial and sporadic ALS in Germany. Neurobiol. Aging 2011, 32:548.e1-548.e4.
7. Gellera C., Castellotti B., Riggio M.C., Silani V., Morandi L., Testa D., Casali C., Taroni F., Di Donato S., Zeviani M., Mariotti C. Superoxide dismutase gene mutations in Italian patients with familial and sporadic amyotrophic lateral sclerosis: identification of three novel missense mutations. Neuromuscul. Disord. 2001, 11:404-410.
8. Gijselinck I., Sleegers K., Engelborghs S., Robberecht W., Martin J.J., Vandenberghe R., Sciot R., Dermaut B., Goossens D., van der Zee J., De Pooter T., Del-Favero J., Santens P., De Jonghe P., De Deyn P.P., Van Broeckhoven C., Cruts M. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol. Aging 2009, 30:1329-1331.
9. Gros-Louis F., Larivière R., Gowing G., Laurent S., Camu W., Bouchard J.P., Meininger V., Rouleau G.A., Julien J.P. Aframeshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J.Biol. Chem. 2004, 279:45951-45956.
10. Guerreiro R.J., Schymick J.C., Crews C., Singleton A., Hardy J., Traynor B.J. TDP-43 is not a common cause of sporadic amyotrophic lateral sclerosis. PLoS One 2008, 3:e2450.
11. Hand C.K., Devon R.S., Gros-Louis F., Rochefort D., Khoris J., Meininger V., Bouchard J.P., Camu W., Hayden M.R., Rouleau G.A. Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis. Arch. Neurol. 2003, 60:1768-1771.
12. Herzfeld T., Wolf N., Winter P., Hackstein H., Vater D., Müller U. Maternal uniparental heterodisomy with partial isodisomy of a chromosome 2 carrying a splice acceptor site mutation (IVS9-2A>T) in ALS2 causes infantile-onset ascending spastic paralysis (IAHSP). Neurogenetics 2009, 10:59-64.
13. Johnson J.O., Pioro E.P., Boehringer A., Chia R., Feit H., Renton A.E., Pliner H.A., Abramzon Y., Marangi G., Winborn B.J., Gibbs J.R., Nalls M.A., Morgan S., Shoai M., Hardy J., Pittman A., Orrell R.W., Malaspina A., Sidle K.C., Fratta P., Harms M.B., Baloh R.H., Pestronk A., Weihl C.C., Rogaeva E., Zinman L., Drory V.E., Borghero G., Mora G., Calvo A., Rothstein J.D., Drepper C., Sendtner M., Singleton A.B., Taylor J.P., Cookson M.R., Restagno G., Sabatelli M., Bowser R., Chiò A., Traynor B.J. Mutations in the matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 2014, 17:664-666. ITALSGEN Consortium.
14. Kirby J., Goodall E.F., Smith W., Highley J.R., Masanzu R., Hartley J.A., Hibberd R., Hollinger H.C., Wharton S.B., Morrison K.E., Ince P.G., McDermott C.J., Shaw P.J. Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis. Neurogenetics 2010, 11:217-225.
15. Paisan-Ruiz C., Nath P., Wood N., Singleton A., Houlden H. Clinical heterogeneity and genotype-phenotype correlations in hereditary spastic paraplegia because of Spatacsin mutations. Eur. J. Neurol. 2008, 15:1065-1070.
16. Ramasamy A., Trabzuni D., Guelfi S., Varghese V., Smith C., Walker R., De T., Coin L., de Silva R., Cookson M.R., Singleton A.B., Hardy J., Ryten M., Weale M.E. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci. 2014, 17:1418-1428. UK Brain Expression Consortium, North American Brain Expression ConsortiumNorth American Brain Expression Consortium.
17. Sailer A., Scholz S.W., Gibbs J.R., Tucci A., Johnson J.O., Wood N.W., Plagnol V., Hummerich H., Ding J., Hernandez D., Hardy J., Federoff H.J., Traynor B.J., Singleton A.B., Houlden H. Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases. Neurology 2012, 79:127-131.
18. Samaranch L., Riverol M., Masdeu J.C., Lorenzo E., Vidal-Taboada J.M., Irigoyen J., Pastor M.A., de Castro P., Pastor P. SPG11 compound mutations in spastic paraparesis with thin corpus callosum. Neurology 2008, 71:332-336.
19. Stevanin G., Azzedine H., Denora P., Boukhris A., Tazir M., Lossos A., Rosa A.L., Lerer I., Hamri A., Alegria P., Loureiro J., Tada M., Hannequin D., Anheim M., Goizet C., Gonzalez-Martinez V., Le Ber I., Forlani S., Iwabuchi K., Meiner V., Uyanik G., Erichsen A.K., Feki I., Pasquier F., Belarbi S., Cruz V.T., Depienne C., Truchetto J., Garrigues G., Tallaksen C., Tranchant C., Nishizawa M., Vale J., Coutinho P., Santorelli F.M., Mhiri C., Brice A., Durr A. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 2008, 131:772-784. SPATAX consortium.
20. Stewart H.G., Andersen P.M., Eisen A., Weber M. Corticomotoneuronal dysfunction in ALS patients with different SOD1 mutations. Clin. Neurophysiol. 2006, 117:1850-1861.
21. Suzuki N., Aoki M., Warita H., Kato M., Mizuno H., Shimakura N., Akiyama T., Furuya H., Hokonohara T., Iwaki A., Togashi S., Konno H., Itoyama Y. FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion. J. Hum. Genet. 2010, 55:252-254.
22. Vance C., Rogelj B., Hortobágyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6. Science 2009, 323:1208-1211.
23. Wang K., Li M., Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010, 38:e164.